This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
9640 Medical Center Drive
Rockville, Maryland 20850
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The Company generates i ... more
Executive Director, Finance
Director In the Global Healthcare Group
Co-Chair, Steering Committee
ABFO (Association of Bioscience Finance Officers)
Co-Chairman of the Steering Committee, Baltimore-Washington Chapter of the Financial Officers
Association of Bioscience
University of Notre Dame
MacroGenics to Present Pre-Clinical Data on Targeting CD123-Positive Leukemic Stem Cells at the 55th ASH Annual Meeting (NASDAQ:MGNX)
Senior Management - MacroGenics, Inc.
MacroGenics to Present Pre-Clinical Data on MGD006 at 26th EORTC-NCI-AACR Symposium (NASDAQ:MGNX)
MacroGenics Initiates Phase 1 Study of MGD010 for the Treatment of Autoimmune Disorders (NASDAQ:MGNX)
0001587477 Karrels James 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 SVP, CFO and Secretary
Northwestern Mutual Wealth Management Company
University of Illinois